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EMERGENCE OF AZOLE RESISTANT ASPERGILLUS IN HOSPITALS AND ROLE
OF THE ENVIRONMENT. ONLY A EUROPEAN PROBLEM OR IS ASIA NEXT?
Jacques F. Meis. Department of Medical Microbiology and Infectious
Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands;
Department of Medical Microbiology, Radboud University Medical Center,
Nijmegen, The NetherlandsAspergillus fumigatus, a ubiquitously distributed
opportunistic pathogen, is the global leading
cause of aspergillosis. Azole antifungals play an
important role in the management of aspergil-
losis. However, over a decade azole resistance
in A. fumigatus isolates have been increasingly
reported especially in Western Europe and is
potentially challenging the effective manage-
ment of aspergillosis. The high mortality rates
observed in patients with invasive aspergillosis
caused by azole resistant A. fumigatus isolates
pose serious challenges to the clinical microbiol-
ogist for timely identification of resistance andappropriate therapeutic interventions. The ‘TR34/L98H’ mutation in the
cyp51A gene of Aspergillus fumigatus is responsible for most multi-azole
resistance seen in many European countries, the Middle East, China and In-
dia. Azole-resistant isolates carrying this mutation have been reported from
both patients and the environment. In addition, a new resistance mecha-
nism, TR46/Y121F/T289A, in A. fumigatus conferring high voriconazole
and variable itraconazole MICs was lately described in the Netherlands,
Denmark, Belgium, Germany, France, Tanzania and India. Surprisingly the
Americas and East-Asia have not reported significant azole resistance yet.
Considering that azole antifungals are mainstay of therapy, especially for
chronic invasive and allergic aspergillosis, emergence of resistance espe-
cially in resource limited countries will have profound impact on healthcare.
This presentation highlights the emergence in development of azole resis-
tance in A. fumigatus and the relation with environmental fungicide use.
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THE INFECTION CONTROL OF DENTAL PRACTICE IN TAIWAN
Hsin-Chung Cheng, DDS, MS, PhD. School of Dentistry, Oral Medicine College,
Taipei Medical University, Taipei, Taiwan; Department of Dentistry, Taipei
Medical University Hospital, Taipei, TaiwanIn Taiwan, the compliance rates and importance
of infection control toward dentists were much
lower than physicians before 1990. The situation
has been changed until the occurrence of HIV
cross infection between an oral surgeon and his
patients in 1990, USA. It causes the dentist to
change the way of practice and the attention of
dental infection control. In Taiwan, the first
paper about dental infection control survey was
released in 1998 while the first textbook of dental
infection control in Chinese edition was publi-
cized in 1992. In 1995, the Taipei Dental Associ-
ation was formally established the dentalinfection control committee, formally extended civil dental infection control.
In 2004, the dental global budget of the National Health Insurance began to
perform the “enhanced infection control measurements in dental offices,” at
a reasonable outpatient visits per person subsidy 30 points. Over the past
decade, the implementation of infection control measurements in Taiwan has
significant progress. This report will further describe and analyze the
progressive results and propose the future direction.KS 6
ENVIRONMENTAL CONTROL OF TUBERCULOSIS
Edward A. Nardell, MD. Brigham & Women’s Hospital, Harvard Medical
School, Harvard School of Public Health, Boston, Massachusetts, United
StatesTransmission is the global TB epidemic, in the
community, but most efficiently in congre-
gate settings such as hospitals, clinics,
correctional facilities, and refugee camps.
Effective treatment rapidly stops transmis-
sion, even before sputum acid-fast smear and
culture turn negative. Most transmission is
from persons with unsuspected TB, or unsus-
pected drug resistance, neither of which are
on effective treatment. While active case
finding followed by rapid molecular diagnosis
is the optimal form of TB transmission con-
trol, cases may be missed, treatmentdelayed, and treatment ineffective against highly drug resistant strains.
For these reasons environmental control interventions remain important,
especially in congregate settings. Natural ventilation is the most available
environmental control and can be highly effective, but not in extreme
climates, or at night if windows are closed for cold, security, or to control
vermin. Mechanical ventilation can also be highly effective if well designed
and maintained, but is expensive to install and operate, especially in
extreme climates. Exhaust fans seem logical, but often move air only from in
their immediate vicinity. Upper room ultraviolet (UV) air disinfection is the
most cost effective (cost per equivalent air change) means of air disinfec-
tion, but has been hampered by lack of evidence-based application
guidelines. However, recent studies indicate that highly effective systems
can be planned based on UV fixture output, using computer assisted design,
or simply providing 15 e 20 mW total fixture output per cubic meter room
volume. Room air cleaners employing air filtration, UV, or both technologies,
are convenient, but frequently ineffective interventions due to low clean air
delivery rates (for room volume), short circuiting, and poor design.
Directional airflow in mechanically ventilated buildings helps maintain
separation, but can be difficult to maintain. For all environmental control
interventions, regularly scheduled maintenance is essential for proper
function, but often neglected. Maintenance must be included in any
effective environmental transmission control plan.
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TOP QUALITY IMPROVEMENT INITIATIVES IN 2014-2015
Glenys Harrington, RN, RM . Infection Control Consultancy (ICC), Melbourne,
AustraliaGood quality improvement initiatives address
issues that are of sufficient importance to
stimulate government agencies and healthcare
facility chief executive officers, heads of units
and opinion leaders to continually strive for
strategies to monitor and improve outcomes
for people in their care.
For change and improvement to occur and to
minimise pushback in an organisation, senior
organisational leaders need to be fully sup-
portive of quality improvement initiatives.
Many quality improvement initiatives willinclude the standardisation of care, improving communication and the
collection of relevant and timely information at the point of care.
To support quality improvement in an organisation teams established and
should be inclusive of clinical and non-clinical persons. Ideally there should
also be a person with practical, system and ground level knowledge
overseeing the initiative. In addition keeping up-to-date with the literature
is essential in developing your strategies.
A recent publication by Pageler NM et al (2014) demonstrated the
effectiveness of a multidisciplinary quality improvement strategy using
electronic medical record-enhanced checklists and electronic dashboards
to decrease central line associated bloodstream infections (CLABSIs) in the
paediatric setting.
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has demonstrated the extent of environmental contamination and additional
risks that may be associated with projectile vomiting during norovirus
infection. This will be invaluable information for those managing norovirus
outbreaks.
In addition publications and commentary in the US (Epstein L et al [2014],
Rutala WA and Weber DJ [2014] and Muscarella LF [2014]), relating to
carbapenem-resistant Enterobacteriaceae(CRE) transmission linked to duo-
denoscopes used on patients undergone endoscopic retrograde cholangio-
pancreatography(ERCP) procedures are bringing important issues and
concerns to healthcare providers.
Duodenoscopes are complex and can be difficult to clean. Issues relating to
monitoring/surveillance strategies to identify such infections, training and
credentialing of staff involved in reprocessing and discussions around the
need to shift from disinfection to sterilisation are highlighted in these
publications.
The importance of these publications in identifying critical issues and
enhancing quality improvement will be discussed.KS 8
THE IMPORTANCE OF MANAGEMENT OF THE SURFACE ENVIRONMENT IN
CONTROLLING HEALTHCARE-ASSOCIATED INFECTIONS
David J. Weber, MD, MPH . University of North Carolina, NC, United StatesThis lecture will review the evidence demon-
strating the importance of contamination of
hospital surfaces in the transmission of health-
care-associated pathogens and interventions
scientifically demonstrated to reduce the
levels of microbial contamination and decrease
healthcare-associated infections. It will also
discuss methods to improve cleaning, moni-
toring cleaning effectiveness, new germicides
for surface disinfection, new “no touch”
methods of room disinfection, and “self dis-
infecting” surfaces.The contaminated surface environment in hospitals plays an important role
in the transmission of methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant Enterococcus spp. (VRE), Clostridium difficile, Aci-
netobacter spp., and norovirus. Hospital surfaces are frequently contami-
nated with important healthcare-associated pathogens. Contact with the
contaminated environment by healthcare personnel is equally likely as
direct contact with a patient to lead to contamination of the healthcare
provider’s hands or gloves which may result in patient-to-patient transmis-
sion of nosocomial pathogens. Admission to a room previously occupied by
a patient with MRSA, VRE or C. difficile increases the risk for the subse-
quent patient admitted to the room to acquire the pathogen.
Improved cleaning and disinfection of room surfaces decreases the risk of
healthcare-associated infections. “No-touch” methods of room disinfection
(i.e., devices which produce ultraviolet light or hydrogen peroxide) and
“self-disinfecting” surfaces (e.g., copper) also show promise to decrease
contamination and reduce healthcare-associated infections.KS 9
ALL-TIME TOP INFECTION CONTROL LITERATURE
Robert A. Weinstein, M.D. Cook County Hospital & Rush University Medical
Center, United StatesThe progress in understanding and controlling
healthcare-associated infections over the past
eight decades has been impressive e often
occurring in step-like fashion prompted by
regulators, payers, and patient advocates e
though still a work-in-progress.
The most striking advances worldwide have
been made in control of the “Big 4” (BSIs,
SSIs, VAEs, & UTIs) device- and procedure-
related complications. In part this reflects
improved technology and in part bundled de-
vice-care protocols. These improvements are in
major contrast to difficulties in some countriesin reducing rates of Clostridium difficile infection.
Our efforts to understand and control antimicrobial resistance have been
marked by repeated commissioning of national task forces, controversies
over active surveillance culturing, greatly broadening use of antiseptic
bathing, slow adopting of antimicrobial stewardship, glacially improving
hand hygiene rates, and advancing antibiotic resistance.
Quality improvement programs, especially pay-for-performance and pen-
alty-based movements, have had variable impacts.
Information Technology has improved data capture, facilitated
public reporting and accountability, and opened new approaches for
intervention.
Disinfection and sterilization procedures are effective but await a quantum
leap.
The threat of Ebola virus disease has called needed re-attention to gown,
garb, and environmental concerns.
The molecular era e human genome exploration, bacterial genome
sequencing, and human microbiome analysis e has led to new understand-
ings of health and disease and to rebirth of interventions aimed at
controlling gut flora. Attempts to develop vaccines for nosocomial pathogens
have been unsuccessful. And the aging and increasing immunosuppression of
our patients remain major infection control challenges.
Our advances have depended increasingly on more rigorous study designs,
use of multi-center trials to improve generalizability, and greater sophisti-
cation in our statistical analyses of study outcomes.
The all-time most impactful literature for infection control will be reviewed.KS 10
THE EMERGING GLOBAL CHALLENGE OF NONTUBERCULOUS
MYCOBACTERIAL (NTM) INFECTIONS
David E. Griffith, M.D. The University of Texas Health Sciences Center at
Tyler (UTHSCT), United StatesMycobacterium tuberculosis remains the
most important mycobacterial pathogen
from the perspective of global public health.
It has recently become clear, however, that
diseases caused by nontuberculous mycobac-
terial (NTM) pathogens are being recognized
more frequently in essentially all parts of
the world. This increased recognition is
largely due to the wider availability of
improved microbiological methods utilized
for TB evaluation and diagnosis. Although
the true global burden of NTM disease is un-known, in some industrialized countries, NTM lung disease now occurs
with much greater frequency than TB. It can be reasonably anticipated
that the global prevalence of NTM disease will continue to grow for the fore-
seeable future. The appropriate management of these patients will place
increased demands on already scarce and hard pressed medical care re-
sources. Additionally, new insights into the acquisition of NTM pathogens
from the environment will challenge public health and infection control au-
thorities to create workable NTM disease prevention strategies.KS 11
THE IMPACT OF EMERGING NEW DIAGNOSTIC TECHNIQUES ON CLINICAL
INFECTIOUS DISEASE
Franklin R. Cockerill, MD. Mayo Clinic, United StatesThis Lecture reviews seminal technology devel-
oped in the 20th Century and its important
application to the diagnosis of infectious diseases.
This technology includes immunoassay, flow
cytometry, mass spectroscopy, nucleic acid ampli-
fication (especially PCR) and nucleic acid
sequencing. Examples of applications of these
methods to the detection and quantification of
pathogens and the subsequent dramatic impact on
the effective control and treatment of infectious
diseases are presented. Pathogens include HIV,
